Literature DB >> 28101813

A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.

Lisa A Eaton1, Derrick D Matthews2, Daniel D Driffin3, Leigh Bukowski2, Patrick A Wilson4, Ron D Stall2.   

Abstract

The HIV epidemic among Black men and transgender women who have sex with men (BMTW) demands an urgent public health response. HIV point prevalence among this population ranges from 25 to 43%-a rate far exceeding any other group. Pre-exposure prophylaxis (PrEP) for HIV prevention is a very promising prevention tool; however, its full potential to slow the epidemic has yet to be realized. For the current study, random time-location sampling at Black Gay Pride Events was used to collect data from N = 1274 BMTW, from five US cities, reporting HIV-negative/unknown status. In-field HIV testing was also provided to participants. Participants were assessed on awareness and use of PrEP, health care factors, HIV testing history, psychosocial variables, and sex behaviors. About one third of participants were aware of PrEP (39%), and a small percentage of participants were users of PrEP (4.6%). In multivariable analyses, being in a relationship, testing for HIV in the past 6 months, and others being aware of one's sexuality were positively associated with PrEP awareness. Higher levels of internalized homophobia and greater numbers of female sex partners were positively associated with PrEP use, while education and condom use were negatively associated. Based on study findings, messaging and uptake of PrEP needs greater expansion and requires novel approaches for scale-up. Improving linkage to HIV testing services is likely critical for engaging BMTW with PrEP. The potential for PrEP to slow the HIV epidemic is high; however, we must strengthen efforts to ensure universal availability and uptake.

Entities:  

Keywords:  Black men and transgender women; HIV prevention; Pre-exposure prophylaxis

Mesh:

Year:  2017        PMID: 28101813      PMCID: PMC5926200          DOI: 10.1007/s11121-017-0756-6

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  41 in total

Review 1.  Primary care and public health partnerships for implementing pre-exposure prophylaxis.

Authors:  Wynne E Norton; R Sam Larson; James W Dearing
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

2.  Uptake of PrEP for HIV slow among MSM.

Authors:  Tony Kirby; Michelle Thornber-Dunwell
Journal:  Lancet       Date:  2014-02-01       Impact factor: 79.321

3.  Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

Authors:  Dawn K Smith; Lisa A Grohskopf; Roberta J Black; Judith D Auerbach; Fulvia Veronese; Kimberly A Struble; Laura Cheever; Michael Johnson; Lynn A Paxton; Ida M Onorato; Alan E Greenberg
Journal:  MMWR Recomm Rep       Date:  2005-01-21

4.  Post-exposure prophylaxis for HIV infection in gay and bisexual men. Implications for the future of HIV prevention.

Authors:  S C Kalichman
Journal:  Am J Prev Med       Date:  1998-08       Impact factor: 5.043

5.  Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.

Authors:  Albert Y Liu; Pravina V Kittredge; Eric Vittinghoff; H Fisher Raymond; Katherine Ahrens; Tim Matheson; Jennifer Hecht; Jeffrey D Klausner; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

6.  Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event.

Authors:  Lisa A Eaton; Daniel D Driffin; Harlan Smith; Christopher Conway-Washington; Denise White; Chauncey Cherry
Journal:  Sex Health       Date:  2014-07       Impact factor: 2.706

Review 7.  Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review.

Authors:  Jeffrey H Herbst; Elizabeth D Jacobs; Teresa J Finlayson; Vel S McKleroy; Mary Spink Neumann; Nicole Crepaz
Journal:  AIDS Behav       Date:  2007-08-13

8.  The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.

Authors:  Ide Cremin; Ramzi Alsallaq; Mark Dybul; Peter Piot; Geoffrey Garnett; Timothy B Hallett
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

9.  Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates.

Authors:  David W Purcell; Christopher H Johnson; Amy Lansky; Joseph Prejean; Renee Stein; Paul Denning; Zaneta Gau; Hillard Weinstock; John Su; Nicole Crepaz
Journal:  Open AIDS J       Date:  2012-09-07

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  64 in total

1.  Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago.

Authors:  Gregory Phillips; Anand Raman; Dylan Felt; Ying Han; Brian Mustanski
Journal:  AIDS Behav       Date:  2019-10

2.  Mapping Potential Pre-Exposure Prophylaxis Users onto a Motivational Cascade: Identifying Targets to Prepare for Implementation in China.

Authors:  Yumeng Wu; Lu Xie; Siyan Meng; Jianhua Hou; Rong Fu; Huang Zheng; Na He; Kathrine Meyers
Journal:  LGBT Health       Date:  2019-06-06       Impact factor: 4.151

3.  Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.

Authors:  Matthew Garnett; Yael Hirsch-Moverman; Julie Franks; Eleanor Hayes-Larson; Wafaa M El-Sadr; Sharon Mannheimer
Journal:  AIDS Care       Date:  2017-08-09

4.  Injection drug use, unknown HIV positive status, and self-reported current PrEP use among Black men who have sex with men attending U.S. Black pride events, 2014-2017.

Authors:  Jessica L Maksut; Rachel E Gicquelais; Kevon-Mark Jackman; Lisa A Eaton; M Revel Friedman; Derrick D Matthews; Leigh A Bukowski; Ron D Stall
Journal:  Drug Alcohol Depend       Date:  2019-12-16       Impact factor: 4.492

5.  Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men.

Authors:  Lisa A Eaton; Derrick D Matthews; Leigh A Bukowski; M Ruvel Friedman; Cristian J Chandler; Darren L Whitfield; Jordan M Sang; Ron D Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

6.  Characteristics of the Provider-Patient Encounter Associated With Awareness of and Willingness to Take PrEP Among Young Minority Urban Males in Baltimore City.

Authors:  Aruna Chandran; Arik V Marcell; Renata Arrington Sanders; Jamie Perin; Kathleen R Page; Penny S Loosier; Patricia J Dittus; Jacky M Jennings
Journal:  AIDS Educ Prev       Date:  2019-06

7.  Links Between Sexual Orientation and Disclosure Among Black MSM: Sexual Orientation and Disclosure Matter for PrEP Awareness.

Authors:  Ryan J Watson; Lisa A Eaton; Jessica L Maksut; Katherine B Rucinski; Valerie A Earnshaw
Journal:  AIDS Behav       Date:  2020-01

8.  Threefold Increase in PrEP Uptake Over Time with High Adherence Among Young Men Who Have Sex With Men in Chicago.

Authors:  Ethan Morgan; Kevin Moran; Daniel T Ryan; Brian Mustanski; Michael E Newcomb
Journal:  AIDS Behav       Date:  2018-11

9.  Pre-exposure Prophylaxis (PrEP) Awareness and Use Within High HIV Transmission Networks.

Authors:  Kellie Schueler; Matthew Ferreira; Georgios Nikolopoulos; Britt Skaathun; Dimitrios Paraskevis; Angelos Hatzakis; Samuel R Friedman; John A Schneider
Journal:  AIDS Behav       Date:  2019-07

10.  Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.

Authors:  Emilia M Jalil; Beatriz Grinsztejn; Luciane Velasque; Alessandra Ramos Makkeda; Paula M Luz; Ronaldo I Moreira; Luciana Kamel; Nilo M Fernandes; Ana Cristina G Ferreira; Brenda Hoagland; Sandra Wagner; Albert Liu; Willi McFarland; Susan Buchbinder; Valdilea G Veloso; Erin Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.